Clinical Trials Market Insights: Key Drivers, and Future Outlook 2025
The global clinical trials market has emerged as a vital cornerstone of the healthcare sector, driven by an ever-increasing ...
pharmaphorum1d
Flipping the paradigm – how should biotechs harness adaptive trials?
The final piece of the jigsaw is the FDA itself, and although it updated guidance on adaptive clinical trials last October, Harris would still like to see more leadership from the regulator so ...
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...
pharmaphorum9d
EDI in clinical research: The case for adaptive strategies at every step
As we continue to discuss and tackle the problem of underrepresentation in clinical trials, we are also expanding our scope of involvement and inclusivity. The conversations are becoming broader ...
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
Analytics Insight14d
AI-Driven Transformation in Clinical Trials: Enhancing Efficiency and Compliance
The integration of Artificial Intelligence (AI) and Machine Learning (ML) in clinical trial statistical programming has ...
Applied Clinical Trials Online7d
Leveraging Technology for Efficient Trial Design
Teams must work together with technology solutions and optimize integration to unlock their full potential. Clinical trials ...
The American Journal of Managed Care16d
Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.
Morningstar3d
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
Cognixion clinical trial findings are expected to refine the ... ALS Association mission by expediting the commercialization of adaptive/assistive technologies, medical devices, diagnostics ...